Drug repurposing for neurodegenerative diseases

Area of Science:

• Neuroscience
• Pharmacology
• Gerontology

Background:

• Neurodegenerative diseases (NDDs) are progressive neuronal disorders affecting the brain and spinal cord, leading to sensory and motor dysfunction.
• Common NDDs include Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS).
• The prevalence of NDDs increases with age, posing significant challenges in elderly populations, with a global impact affecting over a billion individuals.

Purpose of the Study:

• To explore the potential of drug repurposing as an efficient, safe, and cost-effective approach for treating NDDs.
• To identify and discuss repurposed drugs for the treatment of major neurodegenerative diseases.
• To highlight the need for further research into underlying mechanisms and molecular details of NDDs for improved therapeutic targets.

Main Methods:

• Review and discussion of existing literature on drug repurposing for neurodegenerative diseases.
• Analysis of current medications' efficacy in treating NDDs.
• Identification of potential therapeutic targets to alter disease pathology.

Main Results:

• Drug repurposing presents a promising avenue for developing effective treatments for NDDs.
• Several drugs are being evaluated for their efficacy in treating AD, PD, HD, MS, and ALS.
• Early detection strategies and drug repurposing are key steps towards better NDD management.

Conclusions:

• Drug repurposing offers a viable and efficient strategy to accelerate the development of treatments for neurodegenerative diseases.
• Further research is crucial to fully understand NDD mechanisms and optimize therapeutic interventions.
• This approach can lead to improved patient outcomes and reduced healthcare costs associated with NDDs.